Cargando…
ADAM metallopeptidase domain 10 knockdown enables podocytes to resist high glucose stimulation by inhibiting pyroptosis via MAPK pathway
Diabetic nephropathy (DN) is a common severe microvascular complication of diabetes mellitus, and podocyte damage occurs in the early stages of DN. The urine of patients with various types of glomerular disease presents increased levels of ADAM metallopeptidase domain 10 (ADAM10). The present study...
Autores principales: | Sui, Chunjie, Zhou, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155254/ https://www.ncbi.nlm.nih.gov/pubmed/37153901 http://dx.doi.org/10.3892/etm.2023.11959 |
Ejemplares similares
-
ADAM Metallopeptidase Domain 33 (ADAM33): A Promising Target for Asthma
por: Tripathi, Priya, et al.
Publicado: (2014) -
Association between ADAM metallopeptidase domain 33 gene polymorphism and risk of childhood asthma: a meta-analysis
por: Sun, F.J., et al.
Publicado: (2017) -
ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma
por: Gao, Junjie, et al.
Publicado: (2022) -
Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers
por: Jarosz-Griffiths, Heledd H., et al.
Publicado: (2019) -
Knockdown of ADAM10 inhibits migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis
por: Li, Dan, et al.
Publicado: (2022)